CrushSCI.com
184.7Average days
142Median days
86Fastest days
571Longest days
3592025 publications

Paper Review Records

All Paper Review Records

19 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

91 days

Non-syndromic premature ovarian insufficiency associated with monoallelic LIG4 mutation via haploinsufficiency

Authors
Sha Yu; Xingyu Zhou; Yunhui Lai; Shuyan Tang; Shiling ChenShow moreShow less
Affiliations
1. Department of Gynecology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China; 2. Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou, China; 3. International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 4. Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, ChinaShow moreShow less
Source PDF DOI Publisher page
211 days

Alpelisib enhances cisplatin mediated cytotoxicity in non-mutated, PIK3CA- dependent high-grade serous ovarian cancer

Authors
Megha Mehrotra; Sourav Chakraborty; Elveera Saldanha; Diksha Joshi; Ajit Dhadve; Asmita Sakpal; Pratik Chandrani; Amita Maheshwari; Santosh Menon; Jaya Ghosh; Sudeep Gupta; Pritha RayShow moreShow less
Affiliations
1. Imaging Cell Signalling & Therapeutics Lab, Advanced Centre for Treatment, Research and Education in Cancer-Tata Memorial Centre, Navi Mumbai, India; 2. Homi Bhabha National Institute, Mumbai, India; 3. Computational Biology, Bioinformatics and Crosstalk Lab, Advanced Centre for Treatment, Research and Education in Cancer-Tata Memorial Centre, Navi Mumbai, India; 4. Department of Gynecologic Oncology, Tata Memorial Centre, Mumbai, India; 5. Department of Pathology, Tata Memorial Centre, Mumbai, India; 6. Department of Medical Oncology, Tata Memorial Centre, Mumbai, IndiaShow moreShow less
Source PDF DOI Publisher page
228 days

Single-cell RNA sequencing in ovarian cancer: decoding the tumor microenvironment for personalized therapy

Authors
Usamah Sayed; Shaker Al-Hasnaawei; Hayjaa Mohaisen-Mousa; Renuka Jyothi-S; Priya Priyadarshini-Nayak; Bethanney Janney-J; Gurjant Singh; Ashish Singh-Chauhan; Manoj Kumar-MishraShow moreShow less
Affiliations
1. Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan; 2. College of pharmacy, the Islamic University, Najaf, Iraq; 3. Department of medical analysis, Medical laboratory technique college, the Islamic University of Al Diwaniyah, Al Diwaniyah, Iraq; 4. Department of Medicinal chemistry, Al-Turath University, Baghdad, Iraq; 5. Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, India; 6. Department of Medical Oncology, IMS and SUM Hospital, Siksha ’O’ Anusandhan (Deemed to be University), Bhubaneswar, India; 7. Department of Biomedical, Sathyabama Institute of Science and Technology, Chennai, India; 8. Department of Physiotherapy, University Institute of Allied Health Sciences, Chandigarh University, Chandigarh, India; 9. Division of research and innovation, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; 10. Salale University, Fitche, EthiopiaShow moreShow less
Source PDF DOI Publisher page
118 days

Deep learning-based prediction of gene expression from histopathology identifies NR5A1 as a candidate biomarker and druggable target in high-grade serous ovarian carcinoma

Authors
Prakash Lingasamy; Marta Ostrowska-Leśko; Pantelis Tsakalis; Naisarg Patel; Ilias Chamatidis; Sajitha Lulu Sudhakaran; Joanna Kubik; Marcin Bobiński; Nikos D. Lagaros; Andres Salumets; Vijayachitra ModhukurShow moreShow less
Affiliations
1. Laboratory of Precision and Nanomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia; 2. Celvia CC AS, Tartu, Estonia; 3. Independent Laboratory of Translational Medicine, Chair of Medical Genetics, Medical University of Lublin, Lublin, Poland; 4. Inferesence(INFS), National Technical University of Athens, Athens, Greece; 5. Integrative Multiomics Lab, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, India; 6. Independent Medical Biology Unit, Medical University of Lublin, Lublin, Poland; 7. Division of Obstetrics and Gynaecology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; 8. Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, EstoniaShow moreShow less
Source PDF DOI Publisher page
571 days

Bridging gut microbiota and polycystic ovary syndrome: the mediating role of metabolites and immune pathways via Mendelian randomization and mediation analysis

Authors
Yushan Li; Yan Zhang; Wei Liu; Tao TaoShow moreShow less
Affiliations
1. Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China; 2. Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaShow moreShow less
Source PDF DOI Publisher page
105 days

Delayed initiation of GnRH antagonist in PCOS patients undergoing IVF: a retrospective cohort study of premature ovulation and embryological outcomes

Authors
Nuri Peker; Ayşen Yücetürk; Esra Tığlı; Özge Karaosmanoğlu; Burak Elmas; İlke Özer Aslan; Bülent TıraşShow moreShow less
Affiliations
1. Acibadem Maslak Hospital IVF Center, Istanbul, Turkey; 2. Kütahya Health Sciences University, Kütahya, Turkey; 3. Department of Obstetrics and Gynecology, Acıbadem Mehmet Ali Aydınlar University, İstanbul, TürkiyeShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.